Detalhe da pesquisa
1.
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022.
Gastric Cancer
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634954
2.
Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.
J Pathol
; 261(3): 286-297, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615198
3.
The effect of anastomotic leakage on the incidence of recurrence after tri-modality therapy for esophageal adenocarcinomas.
J Surg Oncol
; 128(2): 218-230, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133757
4.
Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study.
Gastric Cancer
; 26(5): 763-774, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285071
5.
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally.
BMC Cancer
; 22(1): 646, 2022 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35692051
6.
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer.
Gastric Cancer
; 25(5): 906-915, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35763187
7.
Pembrolizumab plus chemotherapy for advanced gastric cancer.
Lancet Oncol
; 25(2): e51, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301693
8.
Claudin-18.2 targeting by zolbetuximab: results of SPOTLIGHT in perspective.
Lancet
; 401(10389): 1630-1631, 2023 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068506
9.
Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine.
Cancer Metastasis Rev
; 33(1): 161-71, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375389
10.
Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
Front Immunol
; 15: 1372272, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38638445
11.
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma.
Commun Med (Lond)
; 4(1): 89, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760583
12.
The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma.
Cell Rep Med
; 4(4): 100990, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075702
13.
SPOTlight on GLOW.
Cell Rep Med
; 4(10): 101233, 2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37852180
14.
Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study.
Ther Adv Med Oncol
; 15: 17588359231162576, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36970109
15.
Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.
Int J Radiat Oncol Biol Phys
; 117(1): 31-44, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224927
16.
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing Tumors.
Cancer Immunol Res
; 11(9): 1237-1252, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368791
17.
Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition.
Oncoimmunology
; 12(1): 2233403, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470057
18.
Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity.
Cancers (Basel)
; 14(20)2022 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291770
19.
Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives.
Cancers (Basel)
; 14(23)2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497271
20.
Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review.
Cancer Treat Rev
; 108: 102418, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689885